[Congenital myotonic dystrophy and hypoxic-ischemic encephalopathy]

[Usefulness of a rapid serum interleukin-6 test combined with C-reactive protein to predict sepsis in newborns with suspicion of infection].

Anales de pediatria (Barcelona, Spain : 2003)·2009

[Special needs of schoolchildren with diabetes mellitus. Point of view of parents and teachers].

Anales de pediatria (Barcelona, Spain : 2003)·2009

[Why are HIV-infected infants still being born in Spain?].

Anales de pediatria (Barcelona, Spain : 2003)·2007

[Tuberculosis outbreak in a school].

Anales de pediatria (Barcelona, Spain : 2003)·2007

[Adverse reaction of pseudoephedrine].

Anales de pediatria (Barcelona, Spain : 2003)·2005

[Variables influencing duration of hospitalization for urinary tract infection].

Anales espanoles de pediatria·2002

[COVID-19: Critical appraisal of the evidence].

Anales de pediatria (Barcelona, Spain : 2003)·2024

[Trends in child and adolescent mental health in Catalonia in the context of the covid-19 pandemic during the 2020-2021 school year].

Anales de pediatria (Barcelona, Spain : 2003)·2023

[Main changes in the «COVID-19 in paediatrics» clinical practice guideline].

Anales de pediatria (Barcelona, Spain : 2003)·2022

[COVID-19 clinical features in primary care: COVIDPAP study].

Anales de pediatria (Barcelona, Spain : 2003)·2022

Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

British journal of haematology·2026

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

British journal of haematology·2026

Cytodiagnostic features of angiofibroma of soft tissue: A review of 16 cases to identify characteristic findings and their diagnostic significance.

Cancer cytopathology·2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Haematologica·2026

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Haematologica·2026

KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications.

Haematologica·2026

Related Experiment Videos

[Congenital myotonic dystrophy and hypoxic-ischemic encephalopathy]

Related Concept Videos

[Usefulness of a rapid serum interleukin-6 test combined with C-reactive protein to predict sepsis in newborns with suspicion of infection].

[Special needs of schoolchildren with diabetes mellitus. Point of view of parents and teachers].

[Why are HIV-infected infants still being born in Spain?].

[Tuberculosis outbreak in a school].

[Adverse reaction of pseudoephedrine].

[Variables influencing duration of hospitalization for urinary tract infection].

[COVID-19: Critical appraisal of the evidence].

[Trends in child and adolescent mental health in Catalonia in the context of the covid-19 pandemic during the 2020-2021 school year].

[Main changes in the «COVID-19 in paediatrics» clinical practice guideline].

[COVID-19 clinical features in primary care: COVIDPAP study].

Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

Cytodiagnostic features of angiofibroma of soft tissue: A review of 16 cases to identify characteristic findings and their diagnostic significance.

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications.

Related Experiment Videos

[Congenital myotonic dystrophy and hypoxic-ischemic encephalopathy]

Related Concept Videos

Related Articles